Brighthouse Financial vs Globe Life
BHF and GL side by side, both in life insurance. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BHF and GL compare
Globe Life is the larger company, worth 4.9 times as much as Brighthouse Financial ($12.3B against $2.5B).
On earnings, Brighthouse Financial is cheaper: it trades at 4.5× trailing earnings, against 10.7× for Globe Life.
Globe Life grew revenue faster over the last twelve months (5.6% versus −9.4% for Brighthouse Financial).
Globe Life keeps more of each dollar of sales as profit, with a net margin of 18.9% compared with 11.9% at Brighthouse Financial.
Globe Life pays a dividend yielding 0.79%; Brighthouse Financial does not pay one.
Globe Life scores higher on the StockData Score (13 against 6 for Brighthouse Financial), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BHF | GL |
|---|---|---|
| Size and price | ||
| Market cap | $2.5B | $12.3B |
| Share price | $44.10 | $160.11 |
| Change, 1 year | −33.0% | 21.0% |
| Change, 5 years | −15.8% | 73.2% |
| Beta (5Y) | 1.08 | 0.55 |
| Employees | 1,400 | 3,695 |
| StockData Score | ||
| Total score | 6 | 13 (better) |
| Valuation score | 5 (better) | 0 |
| Growth score | 0 | 2 (better) |
| Performance score | 1 | 6 (better) |
| Health score | 0 | 1 (better) |
| Dividend score | 0 | 4 (better) |
| Valuation | ||
| P/E | 4.5× (better) | 10.7× |
| P/S | 0.4× (better) | 2.0× |
| P/B | 0.5× (better) | 1.9× |
| P/FCF | – | 9.2× |
| PEG | – | 0.67 |
| FCF yield | – | 10.8% |
| Fair value | $71.41 | $158.48 |
| Margin of safety | 38.2% (better) | −1.0% |
| Growth | ||
| Revenue growth (TTM) | −9.4% | 5.6% (better) |
| Revenue growth, 5Y average | −4.5% | 4.8% (better) |
| Net income growth (TTM) | −29.7% | 3.1% (better) |
| EPS growth (TTM) | −32.0% | 8.3% (better) |
| EPS growth, 5Y average | – | 15.6% |
| Profitability | ||
| Net margin | 11.9% | 18.9% (better) |
| FCF margin | – | 21.3% |
| Return on equity | 12.0% | 19.3% (better) |
| Financial health | ||
| Debt / equity | – | 0.45 |
| Altman Z-score | 0.03 | 0.94 (better) |
| Piotroski F-score | 6 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | – | 0.79% |
| Payout ratio | – | 7.9% |
| Years of dividend growth | – | 16 |
| Dividend growth, 5Y average | – | 7.6% |
| Buyback yield | 0.00% | 6.3% (better) |
| Shareholder yield | 0.00% | 7.1% (better) |
| Ownership | ||
| Held by institutions | 91.3% | 84.7% |
| Held by insiders | 1.4% | 0.85% |
| Insider net buying, 12 months | – | −$82.9M |
| Superinvestors holding | – | 1 |
| Short interest, % of float | – | 2.9% |
Go deeper
- BHF stock overview
- BHF income statement
- BHF valuation and score
- GL stock overview
- GL income statement
- GL valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.